Fauci Ready to Approve a COVID-19 Vaccine Only 50/50 Effective

By Dr. Jerome Corsi

Last Friday, Dr. Anthony Fauci, Director of the NIH Institute for Allergy and Infectious Diseases, made clear that the FDA was prepared to approve a COVID-19 vaccine, even if the vaccine proves only 50 percent effective in preventing a person from contracting the disease. This means the FDA is ready to declare a COVID-19 vaccine as approved under an Emergency Use Authorization (EUA) if there is a 50/50 chance a person could get COVID-19 after taking the vaccine.

Detailed examination of the FDA standards also makes clear that for a COVID-19 vaccine to be approved under an EUA, the FDA must not approve hydroxychloroquine as an approved medication for COVID-19. In other words, official FDA policy is currently rigged to approve the use of a relatively ineffective COVID-19 vaccine provided that hydroxychloroquine remains demonized by the FDA for treatment of COVID-19 despite clinical results worldwide that suggest the efficacy of Dr. Vladimir Zelenko’s protocol (hydroxychloroquine + zinc + azithromycin or doxycycline) for treatment of early stage COVID-19 and prophylaxis.

Fauci’s statement that a COVID-19 vaccine will be approved for COVID-19 under a FDA EUA as long as it is 50 percent effective derives from an FDA policy articulated on July 29, 2020, by Doran Fink, MD, Ph.D., in the FDA/CBER (Center for Biologics Evaluation and Research) Office of Vaccines Research and Review. In a series of eight slides, Dr. Fink articulated the standards for the FDA issuance of Emergency Use Authorization (EUA) for COVID-19 vaccines. [more...]